Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
342191000001118 | Scheriproct ointment (LEO Pharma) 30 gram | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
342201000001116 | Scheriproct ointment (LEO Pharma) 30 gram (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1711971000001118 | Scheriproct ointment (Karo Pharma) 30 gram | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1711981000001116 | Scheriproct ointment (Karo Pharma) 30 gram (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
25777501000001115 | Scheriproct ointment (Schering Health Care Ltd) 30 gram (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
25777601000001116 | Scheriproct ointment (Schering Health Care Ltd) 30 gram | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
38073501000001118 | Scheriproct ointment (Valeant Pharm) 30 gram | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
45324201000001112 | Scheriproct ointment (Valeant Pharmaceuticals Ltd) 30 gram | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
54235501000001118 | Scheriproct ointment (Meda Pharmaceuticals Ltd) 30 gram | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
61928701000001112 | Scheriproct ointment (Bayer Plc) 30 gram | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets